Research strategy

The congenital heart disease service is committed to the developments of improvements in healthcare delivery through quality research and academic activity. Research is an integral part of the service’s mission to constantly improve and be able to offer better care for patients. 

Southampton’s primary research partner, the University of Southampton, is one of the UK’s leading teaching and research universities. Clinical studies are carried out at the NIHR Southampton Clinical Research Facility and are supported by dedicated research staff. 

The congenital heart disease teams in the network engage in a range of teaching and training activities aimed at developing, maintaining and overseeing the development of network staff. 

Activities are run in a collaborative manner at specialist centres in Southampton and Oxford with the support of other clinicians in supporting network hospitals. 

The service is involved in a number of multi-centre and collaborative studies and areas of research include: 

  • Multi-centre study on outcomes following Hybrid-style palliation
  • Study on Fontan physiology (Comparison of exercise physiology in fenestrated versus non-fenestrated Fontan circulations 
  • Nutritional intake in children with congenital heart disease and relationship to growth 
  • Performance of grafts in the right ventricle outflow tract 
  • Analysis of pulmonary arteries post stage one in hypoplastic left heart syndrome 
  • Analysing current practice in the assessment of paediatric chest pain 
  • Medium-term outcomes following aortic arch repair in childhood 
  • Appropriate use criteria in paediatric outpatient echocardiography 
  • Registry review of BioPulmonic valved conduit.

Research Strategy 2021-2025

Patient care is significantly improved through research, innovation and quality improvement; with better outcomes and improved treatment pathways; in addition to providing opportunities and job satisfaction for staff. Hospitals and operational networks which are ‘research active’ have lower mortality rates extending to include those who have not participated in research.

Our vision is ambitious linking an innovative research and quality improvement strategy reflective of the unique needs and priorities of patients, families and health care professionals within the Thames Valley Wessex region.

We will be prioritising research based on four themes identified from the stakeholder engagement NEW-R, complementing the National Institute Health Research Biomedical Research Centres (NIHR-BRC) of our research partners.

Nutrition

Pre-habilitation, perioperative, rehabilitation

Exercise

Physical activity, conditioning

Wellbeing

Decision-making, patient and staff mental health and wellbeing

Resilience

Peri-operative stressors, bench to bedside

Research Strategy 2021-2025

Patient care is significantly improved through research, innovation and quality improvement; with better outcomes and improved treatment pathways; in addition to providing opportunities and job satisfaction for staff. Hospitals and operational networks which are ‘research active’ have lower mortality rates extending to include those who have not participated in research.

Our vision is ambitious linking an innovative research and quality improvement strategy reflective of the unique needs and priorities of patients, families and health care professionals within the Thames Valley Wessex region.

We will be prioritising research based on four themes identified from the stakeholder engagement NEW-R, complementing the National Institute Health Research Biomedical Research Centres (NIHR-BRC) of our research partners.

Nutrition

Pre-habilitation, perioperative, rehabilitation

Exercise

Physical activity, conditioning

Wellbeing

Decision-making, patient and staff mental health and wellbeing

Resilience

Peri-operative stressors, bench to bedside